Betoptik

Roman name

Betoptic

The composition and the form of

1 ml eye drops betaxolola contains 5 mg; in vials to 5 ml with Drop-teiner unit, in a package one flakon.1 ml suspension eye-2.5 mg; in polyethylene bottles to 5 ml, in the box one bottle, or in vials to 10 ml.

Pharmacokinetics

When a local drug Betoptik the possible systemic absorption betaxolola hydrochloride.

Indications

Chronic otkratougolnaya glaucoma, eye inflammation (as a stand alone treatment or in combination with other drugs).

Pregnancy and lactation

Perhaps if the effect of therapy outweighs the potential risk to the fetus. During breast-feeding with caution.

Contraindications

Hypersensitivity, sinusova aetiology, AV blockade II extent cardiogenny shock expressed heart failure in history.

Patient interaction

If you are receiving бета-адреноблокаторо�� inwards to reinforce one another local (vnutriglaznogo lower pressure) and systemic (gipotenzia, aetiology) effects; amidst simpatomimetikov (rezerpin) is probably better Hypotension and bradikardii.

Precautions

Be wary appoint patients with diabetes, thyrotoxicosis, feohromotsytoma, Reynaud syndrome, myasthenia, in the face of adrenergicakih psychotropic substances. There is a need to gradually lift the 48 hours before surgery with the use of general anesthesia. At the first signs of cardiovascular decompensation pathology should stop treatment.

Dosing and Administration

Kongungualno on 1-2 drop twice a day in the afflicted eye (under the supervision vnutriglaznogo pressure).

Storage conditions

List B. The temperature 8-30 ° C. (upright)

Shelf life

3 years

The registration

014741/01-2003

Directory → Organotropona funds → Cardiovascular funds → Beta-adrenoblokatora → Betoptik